Soleno Therapeutics, Inc. (NASDAQ:SLNO) Expected to Announce Earnings of -$0.07 Per Share

Analysts expect that Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Rating) will announce ($0.07) earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have provided estimates for Soleno Therapeutics’ earnings. Soleno Therapeutics posted earnings per share of ($0.14) in the same quarter last year, which indicates a positive year-over-year […]

Related Keywords

,Soleno Therapeutics Inc ,Geode Capital Management ,Soleno Therapeutics Company Profile Get Rating ,Zacks Investment Research ,Blackrock Inc ,Renaissance Technologies ,Nasdaq ,Soleno Therapeutics ,Get Rating ,Zacks Investment ,Soleno Therapeutic ,Investment Research ,Capital Management ,Two Sigma Investments ,Sigma Investments ,Therapeutics Company Profile ,Diazoxide Choline Controlled Release ,Prader Willi Syndrome ,Nasdaq Slno ,Slno ,Medical ,Ratings ,Consensus ,